Accelerate Diagnostics rises on partnership with Becton Dickinson

Accelerate Diagnostics

15/08/2022 14:50

** Shares of Accelerate Diagnostics Inc  AXDX.O  jump ~13%
to $2.40 
    ** Co enters into an agreement with Becton Dickinson and Co
(BD)  BDX.N  to market and sell its testing solutions through
BD's global sales network  urn:newsml:reuters.com:*:nPn1jpsm6a
    ** Agreement includes AXDX's Pheno system, Arc module and
associated test kits that are used for detecting bacterial
infections 
    ** Financial details of the agreement were not disclosed 
    ** Including session gains, stock down 54% YTD

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))